Pulsed Electromagnetic Field Enhances Doxorubicin-induced Reduction in the Viability of MCF-7 Breast Cancer Cells
A pulsed electromagnetic field (PEMF) enhances the efficacy of several anticancer drugs. Doxorubicin (DOX) is an anticancer agent used to treat various malignancies, including breast cancer. This study examined whether a PEMF increases the anticancer effect of DOX on MCF-7 human breast cancer cells...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Society for Clinical Laboratory Science
2024-03-01
|
Series: | Korean Journal of Clinical Laboratory Science |
Subjects: | |
Online Access: | http://www.kjcls.org/journal/view.html?doi=10.15324/kjcls.2024.56.1.73 |